APA (7th ed.) Citation

Täger, T., Atar, D., Agewall, S., Katus, H., Grundtvig, M., Cleland, J. G. F., . . . Frankenstein, L. (2021). Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: A systematic review and network meta-analysis of randomised controlled trials. Heart failure reviews, 26(6), . https://doi.org/10.1007/s10741-020-09954-8

Chicago Style (17th ed.) Citation

Täger, Tobias, Dan Atar, Stefan Agewall, Hugo Katus, Morten Grundtvig, John G. F. Cleland, Andrew L. Clark, Hanna Fröhlich, and Lutz Frankenstein. "Comparative Efficacy of Sodium-glucose Cotransporter-2 Inhibitors (SGLT2i) for Cardiovascular Outcomes in Type 2 Diabetes: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials." Heart Failure Reviews 26, no. 6 (2021). https://doi.org/10.1007/s10741-020-09954-8.

MLA (9th ed.) Citation

Täger, Tobias, et al. "Comparative Efficacy of Sodium-glucose Cotransporter-2 Inhibitors (SGLT2i) for Cardiovascular Outcomes in Type 2 Diabetes: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials." Heart Failure Reviews, vol. 26, no. 6, 2021, https://doi.org/10.1007/s10741-020-09954-8.